We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Tepilta® Versus Oxetacaine, Antacids and Placebo

This study has been terminated.
(The study stopped prematurely due to and administrative reasons, not based on grounds of safety.)
ClinicalTrials.gov Identifier:
First Posted: April 18, 2011
Last Update Posted: May 19, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Trium Analysis Online GmbH
ICON plc
Clinipace Worldwide
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)